[go: up one dir, main page]

ZA200902300B - Use of modified cyclosporins - Google Patents

Use of modified cyclosporins

Info

Publication number
ZA200902300B
ZA200902300B ZA200902300A ZA200902300A ZA200902300B ZA 200902300 B ZA200902300 B ZA 200902300B ZA 200902300 A ZA200902300 A ZA 200902300A ZA 200902300 A ZA200902300 A ZA 200902300A ZA 200902300 B ZA200902300 B ZA 200902300B
Authority
ZA
South Africa
Prior art keywords
cyclosporins
modified
modified cyclosporins
Prior art date
Application number
ZA200902300A
Other languages
English (en)
Inventor
Motoyuki Kohjima
Makoto Nakamuta
Original Assignee
Novartis Ag
Univ Kyushu
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag, Univ Kyushu filed Critical Novartis Ag
Publication of ZA200902300B publication Critical patent/ZA200902300B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Transplantation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
ZA200902300A 2006-10-12 2009-04-02 Use of modified cyclosporins ZA200902300B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US82922806P 2006-10-12 2006-10-12

Publications (1)

Publication Number Publication Date
ZA200902300B true ZA200902300B (en) 2010-10-27

Family

ID=39092021

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200902300A ZA200902300B (en) 2006-10-12 2009-04-02 Use of modified cyclosporins

Country Status (17)

Country Link
US (1) US20100130408A1 (xx)
EP (1) EP2073831A1 (xx)
JP (1) JP5455632B2 (xx)
KR (1) KR20090083902A (xx)
CN (1) CN101557819A (xx)
AU (1) AU2007306316B2 (xx)
BR (1) BRPI0719189A2 (xx)
CA (1) CA2665415A1 (xx)
IL (1) IL197966A0 (xx)
MA (1) MA30865B1 (xx)
MX (1) MX2009003743A (xx)
NO (1) NO20091694L (xx)
RU (1) RU2463071C2 (xx)
SG (1) SG175621A1 (xx)
TN (1) TN2009000135A1 (xx)
WO (1) WO2008043797A1 (xx)
ZA (1) ZA200902300B (xx)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110117055A1 (en) 2009-11-19 2011-05-19 Macdonald James E Methods of Treating Hepatitis C Virus with Oxoacetamide Compounds
CN101843893B (zh) * 2010-05-21 2012-02-01 中国人民解放军第三军医大学 环孢素a在制备抗轮状病毒药物中的应用
WO2011153157A2 (en) * 2010-06-01 2011-12-08 Auspex Pharmaceutical, Inc. Benzoquinolone inhibitors of vmat2
JP6362601B2 (ja) 2012-09-18 2018-07-25 オースペックス・ファーマシューティカルズ・インコーポレイテッドＡｕｓｐｅｘ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ， Ｉｎｃ． 小胞モノアミン輸送体２の重水素化ベンゾキノリン阻害剤の製剤薬物動態
US9550780B2 (en) 2012-09-18 2017-01-24 Auspex Pharmaceuticals, Inc. Formulations pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2
CA2930744A1 (en) 2013-12-03 2015-06-11 Auspex Pharmaceuticals, Inc. Methods of manufacturing benzoquinoline compounds
IL288712B2 (en) 2015-03-06 2024-01-01 Auspex Pharmaceuticals Inc Methods for the treatment of abnormal involuntary movement disorders

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5639724A (en) * 1984-07-24 1997-06-17 Sandoz Ltd. Cyclosporin galenic forms
US5908621A (en) * 1995-11-02 1999-06-01 Schering Corporation Polyethylene glycol modified interferon therapy
FR2757522B1 (fr) * 1996-12-24 1999-01-29 Rhone Poulenc Rorer Sa Derives de cyclosporine, leur preparation et les compositions pharmaceutiques qui les contiennent
FR2757521B1 (fr) * 1996-12-24 1999-01-29 Rhone Poulenc Rorer Sa Nouveaux derives de cyclosporine, leur preparation et les compositions pharmaceutiques qui les contiennent
JPH1180026A (ja) * 1997-09-02 1999-03-23 Yoshitomi Pharmaceut Ind Ltd 新規免疫抑制剤、その使用方法およびその同定方法
US20030216303A1 (en) * 1998-03-06 2003-11-20 Michael Ambuhl Emulsion preconcentrates containing cyclosporin or a macrolide
DE69928938T2 (de) * 1998-07-01 2006-08-17 Debiopharm S.A. Neues cyclosporin mit verbesserter wirkung
AU4144400A (en) * 1999-04-27 2000-11-10 Mitsubishi Pharma Corporation Preventives/remedies for liver diseases
WO2002030464A1 (en) * 2000-10-11 2002-04-18 Daiichi Pharmaceutical Co., Ltd. Novel drugs for liver diseases
US20030213603A1 (en) * 2002-05-14 2003-11-20 Fisher David B. Dual use extension apparatus for a tool
GB0320638D0 (en) * 2003-09-03 2003-10-01 Novartis Ag Organic compounds
US7079552B2 (en) * 2003-09-09 2006-07-18 Harris Corporation Mobile ad hoc network (MANET) with quality-of-service (QoS) protocol hierarchy and related methods
CA2580448C (en) * 2004-10-01 2012-09-18 Debiopharm Sa Use of [d-meala]3-[etval]4-cyclosporin for the treatment of hepatitis c infection and pharmaceutical composition comprising said [d-meala]3-[etval]4-cyclosporin
NZ554514A (en) * 2004-10-01 2010-10-29 Scynexis Inc 3-ether and 3-thioether substituted cyclosporin derivatives for the treatment and prevention of hepatitis C infection
CN101076350A (zh) * 2004-12-23 2007-11-21 诺瓦提斯公司 用于hcv治疗的组合物
US8512690B2 (en) * 2009-04-10 2013-08-20 Novartis Ag Derivatised proline containing peptide compounds as protease inhibitors

Also Published As

Publication number Publication date
CA2665415A1 (en) 2008-04-17
KR20090083902A (ko) 2009-08-04
TN2009000135A1 (en) 2010-10-18
AU2007306316A1 (en) 2008-04-17
JP5455632B2 (ja) 2014-03-26
JP2010505912A (ja) 2010-02-25
MA30865B1 (fr) 2009-11-02
WO2008043797A1 (en) 2008-04-17
BRPI0719189A2 (pt) 2018-08-14
RU2463071C2 (ru) 2012-10-10
MX2009003743A (es) 2009-06-18
IL197966A0 (en) 2011-08-01
NO20091694L (no) 2009-07-10
US20100130408A1 (en) 2010-05-27
RU2009117699A (ru) 2010-11-20
CN101557819A (zh) 2009-10-14
SG175621A1 (en) 2011-11-28
EP2073831A1 (en) 2009-07-01
AU2007306316B2 (en) 2011-10-27

Similar Documents

Publication Publication Date Title
IL196956A0 (en) Aza-benzofuranyl compounds and methods of use
IL197060A0 (en) Aza-benzothiophenyl compounds and methods of use
GB0705854D0 (en) Methods of construction
IL196606A0 (en) Use of escin
ZA200902300B (en) Use of modified cyclosporins
IL192700A0 (en) Use of elderberry extract
GB0605107D0 (en) Use
DK2392335T3 (en) Use of 24-norUDCA
GB0724953D0 (en) Methods of peptide modification
ZA200900896B (en) Aza-benzofuranyl compounds and methods of use
GB0624105D0 (en) Use
ZA200901009B (en) Aza-benzothiophenyl compounds and methods of use
GB0621229D0 (en) Novel use
AP2009004788A0 (en) Novel use
HK1131561A (en) Use of modified cyclosporins
TWM301105U (en) Improved structure of socket
GB0612370D0 (en) Uses of (S)-clenbuterol
GB0603087D0 (en) Novel use
GB0617865D0 (en) Novel use
GB0605931D0 (en) Endoscope
PL381142A1 (pl) Sposób otrzymywania glicydolu
GB0602857D0 (en) The treatment of sialorrhoea
TWM311768U (en) Improved structure of A-ladder
PL379090A1 (pl) Wykorzystanie wodoru
ZA200810632B (en) Derivativs and analogs of N-ethylquinolones and N-ethylazaquinolones